Expired activity
Please go to the PowerPak homepage and select a course.

Addressing Common Patient Concerns Regarding Biosimilars

This continuing education activity is provided by Vindico Medical Education and supported by an educational grant from Pfizer, Inc.


Activity Chair:
Jonathan Kay, MD
Timothy S. and Elaine L. Peterson Chair in Rheumatology
Professor of Medicine
University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, MA

Edward Li, PharmD, BCOP
Professor of Medicine
Department of Pharmacy Practice
University of New England College of Pharmacy
Portland, ME


In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Activity Chair, Steering Committee, and Faculty report the following relationship(s):

Activity Chair, Steering Committee, and Faculty Relationship identified with
Jonathan Kay, MD Consulting Fee: Amgen, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Janssen, Merck, Pfizer, Roche, Samsung, Sandoz, UCB
Contracted Research (Paid to Institution): AbbVie, Genentech, Pfizer, UCB
Edward Li, PharmD, BCOP No relevant financial relationships to disclose.
Reviewer Relationship identified with
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP No relevant financial relationships to disclose.
Jennifer Frederick PharmD, BCPS No relevant financial relationships to disclose.
Staff Relationship identified with
Vindico Medical Education No relevant financial relationships to disclose.


Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is acceptable for 0.25 contact hour(s) of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-17-009-H01-P, effective 12/15/2017. This is a knowledge-based activity and there is no fee to attend.

This continuing medical education activity is provided by Vindico Medical Education.

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Published: December 20, 2017
Expires: December 19, 2018
Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.

Estimated time to complete activity: 20 minutes


The intended audience for this activity is gastroenterologists, hematologists-oncologists, rheumatologists, pharmacists, and other health care professionals involved in the treatment of patients that benefit from biologic therapy.

How to Earn Credit

During the period December 15, 2017 through December 14, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 75% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 75%, you will receive a message notifying you that you did not pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.


Upon completion of this program, participants should be better able to:

  • Define barriers that impede the use of biosimilars and strategies to overcome these challenges.


Please ensure the computer system you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.